phenformin has been researched along with Breast Neoplasms in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (64.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar-Mahecha, A; Ahn, R; Avizonis, D; Basik, M; Cepeda Cañedo, E; Chabot, C; Dankner, M; Goulet, ML; Hébert, S; Im, YK; Kleinman, CL; Kuasne, H; La Selva, R; Lebeau, B; Lewis, K; Lin, R; Martínez, C; Najyb, O; Nguyen, A; Park, M; Petrecca, K; Pollak, M; Sabourin, V; Santos Martínez, N; Savage, P; Siegel, PM; St-Pierre, J; Topisirovic, I; Totten, SP; Ursini-Siegel, J; Witcher, M | 1 |
| Aleidi, SM; Alsalamat, HA; Bardaweel, SK; Bashatwah, RM | 1 |
| Albini, A; Bertolini, F; Calleri, A; Dallaglio, K; Gregato, G; Labanca, V; Mancuso, P; Noonan, DM; Orecchioni, S; Reggiani, F; Talarico, G | 1 |
| Liu, C; Liu, Z; Ren, L; Wang, S; Xia, T; Zha, X | 1 |
| Alessi, DR; Appleyard, MV; Bray, SE; Coates, PJ; Fleming, S; Kernohan, NM; Murray, KE; Thompson, AM; Wullschleger, S | 1 |
| Pezzino, V; Purrello, F; Trischitta, V; Vigneri, R | 1 |
| Avola, R; Cohen, D; D'Agata, R; Pezzino, V; Polosa, P; Vigneri, R | 1 |
| Goldfine, ID; Pezzino, V; Vigneri, R; Wong, KY | 1 |
| Berstein, LM; Buslaeva, VP; Dilman, VM; Fedorov, SN; Kondratjev, VB; Nemirovsky, VS; Nikiforov, YF; Ostroumova, MN; Poroshina, TE; Seleznev, IK; Semiglazov, VF; Tsyrlina, EV; Vasilyeva, IA | 1 |
| Bershteĭn, LM; Dil'man, VM; Ostroumova, MN; Vasil'eva, IA | 1 |
| Bershteĭn, LM; Buslaeva, VP; Kondrat'ev, VB; Ostroumova, MN; Semiglazov, VF | 1 |
| Dilman, VM; Ostroumova, MN; Tsyrlina, EV | 1 |
| Bershteĭn, LM; Bobrov, IuF; Dil'man, VM; Kovaleva, IG; Tsyrlina, EV | 1 |
| Dil'man, VM; Kirsanov, AI; Kovaleva, IG; Riabov, SI; Tsyrlina, EV | 1 |
14 other study(ies) available for phenformin and Breast Neoplasms
| Article | Year |
|---|---|
STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Synergism; Electron Transport Complex I; Energy Metabolism; Female; Glutathione; Humans; Interferon-gamma; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Knockout; Mice, SCID; NAD(P)H Dehydrogenase (Quinone); Naphthoquinones; Oxidative Stress; Phenformin; Poly I-C; Reactive Oxygen Species; STAT1 Transcription Factor; Xenograft Model Antitumor Assays | 2021 |
Glucose Deprivation Enhances the Antiproliferative Effects of Oral Hypoglycemic Biguanides in Different Molecular Subtypes of Breast Cancer: an in Vitro Study.
Topics: Administration, Oral; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Glucose; Humans; Hypoglycemic Agents; Metformin; Phenformin | 2018 |
The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Electron Transport Complex I; Female; Humans; Metformin; Mice; Neoplasm Metastasis; Neovascularization, Pathologic; Phenformin; Phosphorylation; TOR Serine-Threonine Kinases; Tumor Microenvironment | 2015 |
Phenformin Induces Cell Cycle Change, Apoptosis, and Mesenchymal-Epithelial Transition and Regulates the AMPK/mTOR/p70s6k and MAPK/ERK Pathways in Breast Cancer Cells.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Epithelial-Mesenchymal Transition; Female; Humans; Hypoglycemic Agents; MAP Kinase Signaling System; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Phenformin; Ribosomal Protein S6 Kinases, 70-kDa; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Phenformin as prophylaxis and therapy in breast cancer xenografts.
Topics: Adenylate Kinase; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Enzyme Activation; Female; Histones; Humans; Ki-67 Antigen; Liver; Metformin; Mice; Mice, Nude; Phenformin; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Spleen; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Effect of metformin on insulin binding to receptors in cultured human lymphocytes and cancer cells.
Topics: Breast Neoplasms; Cells, Cultured; Cycloheximide; Humans; Insulin; Lymphocytes; Metformin; Phenformin; Receptor, Insulin | 1982 |
Phenformin increases insulin binding to human cultured breast cancer cells.
Topics: Breast Neoplasms; Cell Line; Female; Humans; Insulin; Kinetics; Phenformin; Receptor, Insulin | 1980 |
Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells.
Topics: Animals; Biguanides; Breast Neoplasms; Cell Line; Female; Fibroblasts; Humans; Insulin; Liver Neoplasms, Experimental; Lymphocytes; Metformin; Phenformin; Rats; Receptor, Insulin; Sulfonylurea Compounds | 1982 |
Metabolic immunodepression and metabolic immunotherapy: an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances.
Topics: Age Factors; Body Weight; Breast Neoplasms; Clofibrate; Female; Hormones; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Leukocyte Count; Lipids; Lymphocyte Activation; Mastectomy; Middle Aged; Phenformin; Time Factors | 1982 |
[Effect of phenformin and miscleron on the blood somatomedin activity level in breast cancer].
Topics: Adult; Aged; Breast Neoplasms; Clofibrate; Female; Humans; Hyperlipidemias; Middle Aged; Phenformin; Somatomedins; Uterine Neoplasms | 1980 |
[Effect of fenformin and miscleron on the delayed hypersensitivity reaction in breast cancer patients].
Topics: Breast Neoplasms; Clofibrate; Dinitrochlorobenzene; Drug Therapy, Combination; Female; Humans; Hypersensitivity, Delayed; Hypolipidemic Agents; Middle Aged; Phenformin; Skin Tests; Time Factors | 1980 |
Hypothalamic mechanisms of ageing and of specific age pathology--II. on the sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in adaptive homestasis.
Topics: Adaptation, Physiological; Adult; Aged; Aging; Animals; Breast Neoplasms; Corticosterone; Dexamethasone; Female; Homeostasis; Humans; Hydroxysteroids; Hypothalamo-Hypophyseal System; Male; Middle Aged; Phenformin; Rats | 1979 |
[Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin].
Topics: Adrenal Cortex Hormones; Aged; Biguanides; Blood Glucose; Body Weight; Breast Neoplasms; Buformin; Cholesterol; Clofibrate; Colonic Neoplasms; Endocrine System Diseases; Fatty Acids; Female; Growth Hormone; Humans; Insulin; Lipoproteins; Lung Neoplasms; Middle Aged; Neoplasms; Phenformin; Phenytoin; Phospholipids; Triglycerides; Uric Acid; Uterine Neoplasms | 1975 |
[A decrease in body weight, cholesterol and blood sugar under the influence of phenformin (phenylbiguanide) in patients with cancer and atherosclerosis].
Topics: Adult; Antineoplastic Agents; Arteriosclerosis; Blood Glucose; Body Weight; Breast Neoplasms; Cholesterol; Female; Humans; Male; Middle Aged; Phenformin; Uterine Neoplasms | 1972 |